Clinical Trials Logo

Myeloid Sarcoma clinical trials

View clinical trials related to Myeloid Sarcoma.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT02658487 Active, not recruiting - Clinical trials for Acute Myeloid Leukemia

Vosaroxin and Infusional Cytarabine in Treating Patients With Untreated Acute Myeloid Leukemia

VITAL
Start date: March 2016
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well vosaroxin and cytarabine work in treating patients with untreated acute myeloid leukemia. Drugs used in chemotherapy, such as vosaroxin and cytarabine, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.

NCT ID: NCT01371981 Active, not recruiting - Clinical trials for Acute Myeloid Leukemia

Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Start date: June 20, 2011
Phase: Phase 3
Study type: Interventional

This randomized phase III trial studies how well bortezomib and sorafenib tosylate work in treating patients with newly diagnosed acute myeloid leukemia. Bortezomib and sorafenib tosylate may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Giving bortezomib and sorafenib tosylate together with combination chemotherapy may be an effective treatment for acute myeloid leukemia.